Comprehensive Risk Assessment of People With Silicosis: A Population-based Study

July 5, 2018 updated by: Ho Yu CHENG, Chinese University of Hong Kong

Objectives: This study aims to explore the risk profiles among people with silicosis in Hong Kong underpinned by the Pittsburgh Mind-Body Center model.

Design and subjects: This study will adopt a cross-sectional study design with sampling stratified by participants' degree of incapability. 320 Chinese people diagnosed with silicosis and registered with the Pneumoconiosis Compensation Fund Board will be recruited.

Data collection: A demographic data sheet and the St. George's Respiratory Questionnaire will be used to collect the socio-demographic and clinical characteristics of the participants. The behavioral factors (smoking, drinking, physical activity level, consumption of vegetable and fruits and plasma vitamin C level) as well as the psychological risk factors (anxiety and depressive symptoms, and social support) will be examined by validated questionnaires. Biological and physiological parameters, including insulin resistance, C-reactive protein, hemoglobin, fasting blood glucose and lipid profiles, will be ascertained by fasting blood sample.

Data analysis and expected outcomes: The findings of this study will create the database profile of the physical, psychosocial and disease specific aspects among people with silicosis in Hong Kong, subsequently forming the empirical basis of an intervention to tackle the identified modifiable risks among them.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

390

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong SAR, China
        • The Nethersole School of Nursing, Chinese University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

A convenience sample of 390 eligible participants registered with the Pneumoconiosis Compensation Fund Board will be recruited with stratification by their degree of incapacity [(i) <30%, (ii) 30% - 60%, and (iii) >60%], in which the minimal number of participants in each strata will be 30.

Description

Inclusion Criteria:

  • Hong Kong Chinese-speaking residents and Chinese ethnicity;
  • diagnosis of silicosis and confirmed by the Pneumoconiosis Medical Board
  • registered with the Pneumoconiosis Compensation Fund Board (PCFB); and
  • able and willing to give informed written consent

Exclusion Criteria:

  • With medically diagnosed mental illness, including major depression, or
  • with active pulmonary tuberculosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
people with silicosis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory symptoms and related physical limitation
Time Frame: baseline
examined by Hong Kong Chinese version of St. George's Respiratory Questionnaire
baseline
Psychological status
Time Frame: baseline
Anxiety and depression symptoms measured by the Chinese version of Hospital Anxiety and Depression Scale
baseline
Quality of life
Time Frame: baseline
examined by the SF-12v2
baseline
Social support
Time Frame: baseline
measured by the Chinese version of six-item Social Support Questionnaire
baseline
Body mass index
Time Frame: baseline
BMI in kg/m^2
baseline
waist circumference
Time Frame: baseline
WC in cm
baseline
12-hour fasting lipid profile
Time Frame: baseline
total-cholesterol, HDL-Cholesterol, LDL-cholesterol and triglycerides (in mmol/L)
baseline
12-hour fasting glucose
Time Frame: baseline
FG in mmol/L
baseline
fasting insulin level
Time Frame: baseline
insulin in pmol/L
baseline
12 hour fasting ascorbic acid level
Time Frame: baseline
vit-C in mg/dL
baseline
fasting high sensitivity C-reactive protein level
Time Frame: baseline
hs-CRP in mg/L
baseline
hemoglobin level
Time Frame: baseline
hemoglobin in g/dL
baseline
smoking and drinking habits, vegetable and fruit intake
Time Frame: baseline
questions adopted from the Behavioral Risk Factor Surveillance of the Department of Health, Hong Kong SAR
baseline
Physical activity level
Time Frame: baseline
measured by the International Physical Activity Questionnaire - Short Form
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ho Yu CHENG, PhD, RN, The Nethersole School of Nursing, Chinese University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

April 1, 2017

Study Completion (Actual)

April 1, 2017

Study Registration Dates

First Submitted

May 30, 2016

First Submitted That Met QC Criteria

June 5, 2016

First Posted (Estimate)

June 9, 2016

Study Record Updates

Last Update Posted (Actual)

July 6, 2018

Last Update Submitted That Met QC Criteria

July 5, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Silicosis

Clinical Trials on People with silicosis

3
Subscribe